LCTX insider buying
2 cluster buysLineage Cell Therapeutics, Inc. · Healthcare
When two or more insiders at Lineage Cell Therapeutics, Inc. buy LCTX in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in LCTX plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Nov 21, 2024 – Jan 27, 2025Detected Jan 27, 2025Executive buyer5 insidersTotal bought$6.1MMarket cap$331.6M
- May 24 – Aug 16, 2024Detected Aug 16, 2024Executive buyer2 insidersTotal bought$19.8KMarket cap$331.6M
All notable open-market buys in LCTX
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Mar 12, 2026 | Director, President and CEO | 15,000 | $1.63 | $24.5K | SEC ↗ |
| Jan 27, 2025 | BROADWOOD CAPITAL INCcluster 10% Owner | 7,894,737 | $0.76 | $6.0M | SEC ↗ |
| Nov 26, 2024 | Samuel George A. IIIcluster General Counsel | 15,000 | $0.60 | $9.0K | SEC ↗ |
| Nov 26, 2024 | Howe Jill Anncluster Chief Financial Officer | 15,000 | $0.59 | $8.9K | SEC ↗ |
| Nov 22, 2024 | Mulroy Michael H.cluster Director | 40,000 | $0.57 | $22.8K | SEC ↗ |
| Nov 21, 2024 | Culley Brian Mcluster Director, President and CEO | 40,000 | $0.60 | $24.0K | SEC ↗ |
| Aug 16, 2024 | Howe Jill Anncluster Chief Financial Officer | 10,500 | $0.89 | $9.3K | SEC ↗ |
| May 24, 2024 | Culley Brian Mcluster Director, President and CEO | 10,000 | $1.05 | $10.5K | SEC ↗ |
More Healthcare stocks with insider cluster buys
LCTX insider buying — FAQ
- Are insiders buying LCTX stock?
- Yes — 5 distinct insiders have bought LCTX (Lineage Cell Therapeutics, Inc.) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Mar 12, 2026.
- How much LCTX stock have insiders bought?
- Insiders have bought a combined $6.1M of LCTX across 8 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in LCTX?
- A cluster buy is two or more distinct Lineage Cell Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying LCTX on the open market within a rolling window. LCTX has 2 detected cluster buys to date.
- Where does this LCTX insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in LCTX
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy LCTX within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding LCTX.